CATALOGO DEI PRODOTTI DELLA RICERCA

BELLUOMINI, LORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 374
EU - Europa 328
AS - Asia 218
AF - Africa 6
SA - Sud America 6
OC - Oceania 3
Totale 935
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 371
IT - Italia 118
CN - Cina 87
SG - Singapore 56
IE - Irlanda 49
SE - Svezia 46
FR - Francia 33
DE - Germania 23
FI - Finlandia 22
HK - Hong Kong 18
RU - Federazione Russa 13
IN - India 12
JP - Giappone 12
KR - Corea 11
CZ - Repubblica Ceca 6
GB - Regno Unito 4
NL - Olanda 4
AU - Australia 3
CO - Colombia 3
EG - Egitto 3
ID - Indonesia 3
IR - Iran 3
KG - Kirghizistan 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BE - Belgio 2
CA - Canada 2
CL - Cile 2
ES - Italia 2
MA - Marocco 2
MY - Malesia 2
UZ - Uzbekistan 2
AM - Armenia 1
AT - Austria 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
EC - Ecuador 1
IL - Israele 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 935
Salva come PNG Salva come JPEG
Città #
Chandler 91
Ashburn 56
Dublin 48
Singapore 39
Verona 36
Beijing 34
Helsinki 15
Hong Kong 15
New York 13
Redmond 13
Seoul 11
Washington 11
Milan 10
Sindelfingen 10
Tokyo 10
Boardman 9
Lawrence 9
Princeton 9
Trento 8
Wilmington 8
Chapel Hill 7
Jacksonville 7
Bengaluru 6
Brno 6
Rome 6
Isola della Scala 5
Jinan 5
Munich 5
Seattle 5
Shenyang 5
Ann Arbor 4
Bussolengo 4
Lappeenranta 4
Lozzo Atestino 4
Amherst 3
Bishkek 3
Brisbane 3
Cairate 3
Dongguan 3
Kebon Manggis 3
Kent 3
Los Angeles 3
Neiva 3
Tanta 3
Amsterdam 2
Arzignano 2
Baku 2
Beauharnois 2
Brussels 2
Chicago 2
Chions 2
Council Bluffs 2
Foggia 2
Hangzhou 2
Hebei 2
Houston 2
Ludhiana 2
Mumbai 2
Novara 2
Oppeano 2
Osio Sotto 2
Parma 2
Pieve Emanuele 2
Ras al-Khaimah 2
San Giovanni Lupatoto 2
Sannomaru 2
Southend 2
Taiyuan 2
Taizhou 2
Tashkent 2
Tehran 2
Thiene 2
Tianjin 2
Xiamen 2
Zhengzhou 2
Almere Stad 1
Central 1
Falkenstein 1
Fremont 1
Fuzhou 1
Guangzhou 1
Haifa 1
Hamburg 1
Hongtong 1
Lombard 1
London 1
Miami 1
Nanchang 1
Nanjing 1
Naples 1
Nettuno 1
Padova 1
Paris 1
Phnom Penh 1
Pullach im Isartal 1
Quito 1
Redwood City 1
Ridgewood 1
Riyadh 1
Sacramento 1
Totale 645
Salva come PNG Salva come JPEG
Nome #
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 82
Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface 58
Exercise prehabilitation in lung cancer: Getting stronger to recover faster 55
Infections and Immunotherapy in Lung Cancer: A Bad Relationship? 51
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center 45
Exploring the Complex Interplay between Myeloid-Derived Suppressor Cells (MDSCs), Interleukins, and Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC) 41
Efficacy and safety of afatinib for non-small-cell lung cancer: state-of-the-art and future perspectives 40
Exercise for counteracting post-acute COVID-19 syndrome in patients with cancer: an old but gold strategy? 40
Effect of exercise on functional capacity in patients with advanced cancer: A meta-analysis of randomized controlled trials 37
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis 35
Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy 33
Exercise in men with prostate cancer: how to move on? 32
Willingness, preferences, barriers, and facilitators of a multimodal supportive care intervention including exercise, nutritional and psychological approach in patients with cancer: a cross-sectional study 30
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 29
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients 27
Implementation outcomes of early nutritional screening and referral for patients with thoracic cancers 25
Selpercatinib in RET-fusion positive metastatic non-small cell lung cancer: achievements and gray areas 23
A Feasibility Study Investigating an Exercise Program in Metastatic Cancer Based on the Patient-Preferred Delivery Mode 20
A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done 20
Antibody-drug conjugates (ADCs) targeting TROP-2 in lung cancer 20
SCLC Treatment in the Immuno-Oncology Era: Current Evidence and Unmet Needs 20
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective 19
Meta-analysis of the prognostic impact of TP53 co-mutations in EGFR-mutant advanced non-small-cell lung cancer treated with tyrosine kinase inhibitors 18
Exercise and bone health in cancer: enemy or ally? 17
HER2 Aberrations in NSCLC: So Close Yet So Far 16
Drive the oncologists into exercise promotion in lung cancer 15
Exploring the role of respiratory microbiome in lung cancer: A systematic review 14
A qualitative study exploring the experiences and perspectives of patients with cancer attending a 12-week exercise program 11
Feasibility of a novel exercise program for patients with breast cancer offering different modalities and based on patient preference 10
Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients 10
Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case Report 9
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications 8
A cross-sectional study evaluating the exercise discussion with oncologist during cancer consultation: the CONNECT study 8
Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk 8
What is the role of physical exercise in the era of cancer prehabilitation? A systematic review 7
Body composition as a modulator of response to immunotherapy in lung cancer: time to deal with it 7
Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New Glories 7
Exploring the feasibility of a combined exercise program for patients with advanced lung or pancreatic cancer 6
Effect of exercise across the head and neck cancer continuum: a systematic review of randomized controlled trials 6
Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody–Drug Conjugates 6
Cross-sectional survey evaluating the psychological impact of the COVID-19 vaccination campaign in patients with cancer: The VACCINATE study 6
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC 5
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study 4
Immune Checkpoint Inhibitor Nivolumab and Radiotherapy in Pretreated Lung Cancer Patients: Efficacy and Safety of Combination 4
EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas 4
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 3
Immune Checkpoint Inhibitors and Radiotherapy in NSCLC Patients: Not Just a Fluke 3
Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment 3
Totale 997
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.128
article - articoli 6.022
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 106
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.256
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 1 0 2 0 0 0 0 0 4
2020/202161 3 3 1 3 2 4 4 8 12 16 5 0
2021/202279 7 22 0 5 3 5 0 6 3 1 7 20
2022/2023279 11 27 21 45 16 68 0 21 32 10 21 7
2023/2024524 11 13 44 44 52 59 52 25 32 58 82 52
2024/202547 47 0 0 0 0 0 0 0 0 0 0 0
Totale 997